Details for Patent: 8,778,924
✉ Email this page to a colleague
Which drugs does patent 8,778,924 protect, and when does it expire?
Patent 8,778,924 protects MOXATAG and is included in one NDA.
This patent has eleven patent family members in six countries.
Summary for Patent: 8,778,924
| Title: | Modified release amoxicillin products |
| Abstract: | An amoxicillin product comprising: at least one modified release component(s), wherein the at least one modified release component(s) comprises at least amoxicillin and a pharmaceutically acceptable carrier; and wherein when administered to a patient or subject in the fed state said amoxicillin product exhibits a pharmacokinetic profile for amoxicillin in the plasma characterized as follows: (1) the ratio of the portion of the AUC as measured from 2 hours post-administration to 5 hours post-administration to the portion of the AUC as measured from administration to 2 hours post-administration is at least 2.0:1; and (2) the ratio of the portion of the AUC as measured from 5 hours post-administration to 12 hours post-administration to the portion of the AUC as measured from administration to 2 hours post-administration is at least 1.1:1. |
| Inventor(s): | Flanner; Henry H. (Montgomery Village, MD), Tolle-Sander; Sanna (North Potomac, MD), Treacy; Donald (Woodbine, MD), Burnside; Beth A. (Bethesda, MD), Clausen; Susan P. (Ijamsville, MD) |
| Assignee: | Shionogi Inc. (Florham Park, NJ) |
| Application Number: | 11/633,315 |
|
Patent Claim Types: see list of patent claims | Compound; Use; |
Drugs Protected by US Patent 8,778,924
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pragma | MOXATAG | amoxicillin | TABLET, EXTENDED RELEASE;ORAL | 050813-001 | Jan 23, 2008 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | METHOD OF TREATING TONSILLITIS AND/OR PHARYNGITIS SECONDARY TO STREPTOCOCCUS PYOGENES IN A ONCE-A-DAY AMOXICILLIN PRODUCT | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,778,924
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2006321782 | ⤷ Sign Up | |||
| Australia | 2006351475 | ⤷ Sign Up | |||
| Canada | 2635378 | ⤷ Sign Up | |||
| Canada | 2635606 | ⤷ Sign Up | |||
| China | 101563466 | ⤷ Sign Up | |||
| European Patent Office | 1968586 | ⤷ Sign Up | |||
| European Patent Office | 1969134 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
